French Childhood Cancer Survivor Study
ConditionChildhood Solid Tumor
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeUp to 18
SponsorInstitut National de la Santé Et de la Recherche Médicale, France
About this trial
The FCCSS is a multicentric national large-scale collaborative population-based study of children treated for a solid tumor before 2000 in France and before the age of 19 years.
The study is concerned by improving knowledge about the long-term effects caused by cancer and its treatments including adverse health and social outcomes.
The main reason of the FCCSS is to estimate the risk of adverse health and social outcomes that may occur after a cancer treatment and to prevent them by providing adapted follow-up care.
The cohort will be followed for up to 20 years from 2011.
Eligibility criteria
Qualifiers
All types of solid childhood cancer in France
Age at diagnosis: Below age 19
Period of diagnosis: between 1st January 1942 and 31st December 1999
Complete identification (first name, last name, date of birth and place of birth)
Disqualifiers
Leukaemia cases
Trial design
Treatments tested in this trial
- Not listed
Trial groups
18,000 Participants
are grouped into 3 trial groupsSponsors and collaborators
Institut National de la Santé Et de la Recherche Médicale, France
Lead sponsor
Ligue contre le cancer, France
Collaborator
National Research Agency, France
Collaborator
Programme hospitalier de recherche clinique, France
Collaborator
Source ClinicalTrials.gov